April 27, 2018 / 11:20 AM / 24 days ago

BRIEF-Miragen Therapeutics Announces New Data Showing Administration Of MRG-110 Improved Tissue Perfusion And Wound Healing

April 27 (Reuters) - miRagen Therapeutics Inc:

* MIRAGEN THERAPEUTICS ANNOUNCES NEW DATA SHOWING ADMINISTRATION OF MRG-110 IMPROVED TISSUE PERFUSION AND WOUND HEALING IN LATE STAGE PRECLINICAL STUDIES

* MIRAGEN THERAPEUTICS INC - MRG-110 APPEARED TO INCREASE VASCULARIZATION AND REPARATIVE TISSUE FORMATION IN TREATED WOUNDS

* MIRAGEN THERAPEUTICS INC - MIRAGEN BELIEVES RESULTS SUPPORT EVALUATION IN HUMAN CLINICAL TRIALS

* MIRAGEN - MRG-110 TREATMENT APPEARED TO LEAD TO MORE WOUNDS UNDERGOING COMPLETE CLOSURE AT EARLIER TIMEPOINTS VERSUS CONTROLS IN HEALTHY NORMAL ANIMALS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below